Gwenaelle Kerforn New Head of Human Resources at AOP Health
Gwenaelle Kerforn joined AOP Orphan Pharmaceuticals GmbH, Member of the AOP Health Group (AOP Health) as Head of Human Resources in October 2022, making her part of the company's Executive Management Team. Her responsibilities include the strategic direction of human resources management and organizational development.
Vienna, December 14, 2022. For Gwenaelle Kerforn, who has a background in organizational development, people are at the heart of any company:
"Employees, placed in positions matching their skillset, develop their potential and consequently make a decisive contribution to a mutually reinforcing culture. This is beneficial for both the company and its employees."
With this in mind, the experienced manager believes it is important for team leaders to continuously ensure that all employees have a voice that is heard. In her experience, this contributes to learning from mistakes, promotes creativity and fosters identification with the company, serving as a foundation for the positive development of everyone involved.
Kerforn: "Success is usually greater and more sustainable within a team. Transparent and open communication is one of the cornerstones of a good team culture. I will bring these and other convictions to the international environment of AOP Health so that we can grow together as an organization and as people. This will lead to sustainable corporate success."
A native of France, she received her master's degree in management from ESCP Business School in France, England and Germany. During her career, she specialized in organizational development and performance management as well as transformation processes and change management. After holding senior positions in international pharmaceutical companies, she most recently worked at Hookipa Biotech GmbH, where she served as Executive Director, People & Organization.
“At AOP Health, we believe that our people are our most valuable resource. As a company that operates in many countries, we are especially pleased that we have been able to recruit an internationally experienced leader like Gwenaelle Kerforn for this important role.”
About AOP Health
The AOP Health Group incorporates several companies including AOP Orphan Pharmaceuticals GmbH with its seat in Vienna, Austria (“AOP Health”). The AOP Health Group is the European pioneer for integrated therapies for rare diseases and in critical care. Over the past 25 years, the Group has become an established provider of integrated therapy solutions operating from its headquarters in Vienna, its subsidiaries and representative offices throughout Europe and the Middle East, as well as through partners worldwide. This development has been made possible by a continually high level of investment in research and development on the one hand and a highly consistent and pragmatic orientation towards the needs of all its stakeholders on the other – especially the patients and their families as well as the doctors and healthcare professionals treating them. Find out more at aop-health.com.
Nina Roth, MAS
Head of Corporate Communications